1Dudley M E,Rosenberg S A.Adoptive Cell Transfer Therapy[J].Semin Oncol,2007,34 (6):524-531.
2Rosenberg S A,Lotze M T,Muul L M,et al.Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer[J].N Engl J Med,1985,313 (23):1485-1492.
3Muul L M,Spiess P J,Director E P,et al.Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma[J].J Immunol,1987,138 (3):989-995.
4Schmidt-Wolf I G,Negrin R S,Kiem H P,et al.Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity[J].J ExpMed,1991,174 (1):139-149.
5Rosenberg S A,Restifo N P,Yang J C,et al.Adoptive cell transfer:a clinical path to effective cancer immunotherapy[J].Nat Rev Cancer,2008,8 (4):299-308.
6Mottet C,Golshayan D.CD4 + CD25 + Foxp3 + regulatory T cells:from basic research to potential therapeutic use[J].Swiss Med Wkly,2007,137 (45-46):625-634.
7Gattinoni L,Powell D J Jr,Rosenberg S A,et al.Adoptive immunotherapy for cancer:building on success[J].Nat Rev Immunol,2006,6 (5):383-393.
4Folkman J. Tumor angiogenesis: Therapeutic implication [J]. NEnglJMed, 1971, 285:1182.
5Folkman J. Angiogenesis: An organizing principle for drug discovery [ J ] ? Nat Rev Drug Discov, 2007, 6 : 273.
6Quesada AR, Medina MA, Alba E. Playing only one instrument may be not enough: Limitations and future of the antiangiogenic treatment of cancer [ J ]. Bioessays, 2007, 29 (11):1159.
7Bergers G, Hanahan D. Modes of resistance to anti - angiogenic therapy [ J]. Nat Rev Cancer, 2008, 8(8) : 592.
8Huang GC, Chen LB. Tumor vasculature and microenvironment normalization: Apossible mechanism of antiangiogenesis therapy [ J ]. Cancer Biother Radiopharm, 2008, 23 (5):661.
9Shojaei F, Ferrara N. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti -angiogenic therapies [ J ]. Drug Resist Updat, 2008, 11 (6):219.
10Fukumura D, Jain RK. Tumor microvasculature and microenvironment : Targets for anti - angiogenesis and normalization [ J]. Microvasc Res, 2007, 74 (2 - 3) : 72.
